Openbookopenbook
Equity
China Bozza Development Holdings Limited(CHBOF)
USD --+0.00%
Reward67High
Risk46Moderate
📊75%Data
Strong 25% profit margin · Revenue growing 107% YoY
CHBOF
+0.0 · +0.00%
USD · PINK
China Bozza Development Holdings Limited | Basic Materials
Growth Machine
Market Cap:8.52M
ℹ️
Reward Rating
67
High
Top 25% (model universe)
75% data coverage
ℹ️
Risk Rating
46
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on CHBOF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is China Bozza Development Holdings Limited?

China Health Technology Group Holding Company Limited, an investment holding company, engages in the forestry management business in the People's Republic of China.

CHBOF · Verdict

Solid reward · moderate risk

CHBOF stands out on growth and cash flow, but watch the valuation signal.

Based on 88% data coverage

CHBOF · Verdict

What’s working & what to watch

Strengths 2

  • Growth89/100

    Revenue +137.2% CAGR

  • Cash flow75/100

    37% free-cash-flow margin

Watchouts 1

  • Valuation44/100

    Below average

Model-based scoring. For information only — not financial advice.

What is China Bozza Development Holdings Limited?

China Health Technology Group Holding Company Limited, an investment holding company, engages in the forestry management business in the People's Republic of China. The company operates through Forestry Business, Ginseng Business, and Horny Goat Weed Business segments. The company is listed on the PINK in USA, operating in the Basic Materials sector, with a market capitalisation of 8.52M, and a P/E ratio of 1.3x.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: High (67)

The scoring profile indicates moderate reward potential, with growth and profitability as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorBasic Materials
Market Cap8.52M
P/E Ratio1.25
Dividend YieldN/A
52 Week High0.055
52 Week Low0.0005
Last AnnualJune
IPO DateN/A
IncorporatedUSA
Shares Outstanding103M
No. of Employees29
IndustryLumber & Wood Production
ExchangePINK
Beta0.849
CurrencyUSD · Reports in CNY
Websitewww.01069.com.cn
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.